• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Relationship between the pathomorphological characteristics of the lungs and surfactant properties in some forms of chronic pneumonia].

作者信息

Nesterov E N, Panevskaia G N, Kobozev G V

出版信息

Arkh Patol. 1978;40(3):54-8.

PMID:580566
Abstract

The minimum surface tension (STmin) and the content of total lipids (TL) and phospholipids (PL) in a surfactant obtained by differential centrifugation of extracts from 56 fragments of lungs resected from 48 patients with segmentary suppurations and bronchiectasia were correlated with the results of morphological and histochemical studies. The controls consisted of 5 lungs from the subjects dying of accidental causes. Areas of interstitial pneumosclerosis, atelectasis and carnification were found to have a high STmin and to contain less than 1 mg of PL per 1 g of the lung tissue, whereas foci of emphysema had a lower STmin and a higher content of PL. These parameters are inversely related. Possible causes of the change of the surfactant condition in chronic pneumonia and practical importance of its examination in resected lungs for a diverse evaluation of the pathological process and the effectiveness of preoperational therapy are discussed.

摘要

相似文献

1
[Relationship between the pathomorphological characteristics of the lungs and surfactant properties in some forms of chronic pneumonia].
Arkh Patol. 1978;40(3):54-8.
2
[Surface-active factor of the lungs (surfactant) in certain diseases of the respiratory organs].
Sov Med. 1975 Aug(8):62.
3
[Changes in the activity of surfactant in pulmonary emphysema and pneumosclerosis].[肺气肿和肺硬化中表面活性剂活性的变化]
Biull Eksp Biol Med. 1973 Feb;74(2):17-20.
4
[Surfactant surface activity and ultrastructural changes in the type-II alveolocytes of fetal and neonatal lungs in experimental inflammation of the maternal lungs].[母体肺部实验性炎症中胎儿及新生儿肺Ⅱ型肺泡上皮细胞表面活性物质的表面活性及超微结构变化]
Biull Eksp Biol Med. 1989 Jun;107(6):753-6.
5
[The surfactant system of patients with chronic suppurative diseases of the lungs undergoing surgical treatment].[接受外科治疗的慢性化脓性肺部疾病患者的表面活性剂系统]
Grudn Khir. 1988 Mar-Apr(2):60-3.
6
[An index of the stability of pulmonary alveoli, determining the state of surfactant in patients with chronic lung diseases].
Eksp Khir Anesteziol. 1972 Jan-Feb;17(1):78-81.
7
Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.急性呼吸窘迫综合征中表面活性剂的化学成分和生物物理活性
J Clin Invest. 1991 Dec;88(6):1976-81. doi: 10.1172/JCI115523.
8
Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.卡氏肺孢子虫肺炎和获得性免疫缺陷综合征患者的肺表面活性物质
Crit Care Med. 2006 Sep;34(9):2370-6. doi: 10.1097/01.CCM.0000234036.19145.52.
9
[Velocity of the pulse wave spread in patients with chronic nonspecific diseases of the lungs].
Vrach Delo. 1968 Sep;9:12-4.
10
[Ultrastructure of the blood-air barrier in comparison with the indices of surfactant surface activity].
Biull Eksp Biol Med. 1988 Nov;106(11):617-21.